VC accommodates Visiogen
This article was originally published in The Gray Sheet
Executive Summary
Synchrony dual optic accommodating intraocular lens maker raises $24 million in a financing round to support clinical development and other efforts relating to its first product. The lead investor was CMEA Ventures. Other supporters included Foundation Medical Partners and Three Arch Partners, according to a Feb. 28 announcement. Synchrony obtained a CE mark in June 2006 and is in pivotal trials in the United States. The IOL, which incorporates a customized spring-loading component to change the eye's focus from near to far, has been implanted in more than 400 patients worldwide, Visiogen says. Accommodating IOLs like Synchrony, HumanOptics' 1CU and Eyeonics' CrystaLens are designed to more closely mimic the behavior of natural lenses to better capture distance, intermediate and near vision in a single product (1"The Gray Sheet" Oct. 9, 2006, p. 12)...